GNTA Logo

Genenta Science S.p.A. (GNTA) 

NASDAQ
Market Cap
$89.57M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
683 of 960
Rank in Industry
379 of 550

Largest Insider Buys in Sector

GNTA Stock Price History Chart

GNTA Stock Performance

About Genenta Science S.p.A.

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company …

Insider Activity of Genenta Science S.p.A.

Over the last 12 months, insiders at Genenta Science S.p.A. have bought $0 and sold $0 worth of Genenta Science S.p.A. stock.

On average, over the past 5 years, insiders at Genenta Science S.p.A. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 25,000 shares for transaction amount of $18,750 was made by Sanders Walter Lloyd (VP, Sales & Marketing) on 2006‑11‑15.

List of Insider Buy and Sell Transactions, Genenta Science S.p.A.

2006-11-15PurchaseVP, Sales & Marketing
25,000
0.0197%
$0.75$18,750
2006-06-23PurchaseVP, Sales & Marketing
56
<0.0001%
$1.63$91
2006-06-15PurchaseVP, Sales & Marketing
577
0.0009%
$1.51$874
2006-05-12Purchasedirector
15,000
0.023%
$1.46$21,900
2004-05-05Sale10 percent owner
940,000
4.8924%
$4.95$4.65M
2004-05-04Sale10 percent owner
6.31M
32.6423%
$4.92$31.05M
2004-05-03Sale10 percent owner
2.75M
14.6019%
$5.05$13.89M
2004-03-23Purchase10 percent owner
5,000
0.0495%
$9.42$47,100
2004-03-16Purchase10 percent owner
5,000
0.0541%
$10.29$51,450
2003-10-20Purchase10 percent owner
5,000
0.0529%
$10.07$50,350
2003-09-10Purchase10 percent owner
5,000
0.0824%
$15.68$78,400

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.